Compare equities side by side
Stocks breaking to new annual highs
S&P 500 oversold value screener
Relative strength momentum leaders
Upcoming earnings dates & reports
Filter and sort all 500 stocks
Today's biggest gainers and losers
Visual sector performance
Abacus Global Management operates as a life settlement and longevity asset manager, acquiring life insurance policies from seniors at discounts to face value and managing them through maturity. The company generates returns through the spread between acquisition cost plus premiums paid versus death benefit proceeds, with performance driven by actuarial accuracy, portfolio diversification across age cohorts, and premium financing efficiency. Recent 68.6% revenue growth reflects aggressive portfolio expansion, though negative operating margins indicate the business remains in investment mode with premium outlays exceeding current policy maturities.
Abacus acquires life insurance policies from seniors typically at 20-40% of face value, pays ongoing premiums (often 3-8% of face value annually), and collects full death benefits upon insured mortality. Target IRRs typically range 8-12% depending on life expectancy accuracy and premium financing costs. Competitive advantages include actuarial modeling expertise to price longevity risk, relationships with policy brokers and institutional capital sources, and scale to diversify across hundreds of lives reducing idiosyncratic mortality variance. The 89.8% gross margin reflects minimal direct costs beyond policy acquisition and premiums, though timing mismatches create negative operating cash flow during portfolio build-out phases.
Actual-to-expected mortality experience across the policy portfolio (variance from actuarial life expectancy tables)
New policy acquisition volume and pricing spreads (discount to face value achieved in competitive bidding)
Premium financing costs and availability of credit facilities to fund ongoing policy payments
Third-party AUM growth and management fee revenue from institutional investors seeking longevity exposure
Regulatory developments affecting life settlement market structure or policy transfer restrictions
Longevity risk from medical advances extending life expectancies beyond actuarial assumptions, delaying death benefit collections and increasing cumulative premium outlays that can turn positive-IRR policies into losses
Regulatory risk including potential state-level restrictions on life settlement transactions, insurable interest requirements, or privacy regulations affecting policy transfer markets
Actuarial model risk if mortality tables prove systematically inaccurate for the specific demographic profile of policy sellers (adverse selection bias)
Increased competition from institutional investors and specialty finance firms entering life settlements driving up policy acquisition prices and compressing spreads
Disintermediation risk if insurance carriers develop direct policy buyback programs offering seniors competitive pricing without broker intermediaries
Liquidity risk from negative $0.2B operating cash flow and below-1.0 current ratio creating dependence on external financing to fund premium payments
Premium financing facility covenants that may restrict operations or force asset sales if portfolio performance deteriorates or mortality experience disappoints
Fair value accounting volatility as actuarial assumption changes or discount rate movements create non-cash earnings swings unrelated to realized cash flows
low - Life settlement returns are driven by biological mortality rather than economic activity, creating non-correlated returns versus traditional asset classes. However, policy acquisition volumes can decline during recessions as fewer seniors sell policies, and institutional capital flows into alternative assets may weaken during risk-off periods affecting third-party AUM growth.
Rising interest rates negatively impact the business through multiple channels: (1) higher premium financing costs directly reduce IRRs on leveraged policy portfolios, (2) increased discount rates lower the present value of future death benefits reducing fair value marks, and (3) competing fixed income yields make longevity assets relatively less attractive to institutional allocators. The 0.94 debt-to-equity ratio suggests meaningful exposure to floating rate premium financing facilities.
Moderate credit exposure through reliance on premium financing facilities to fund ongoing policy payments. Tightening credit conditions or rising credit spreads can increase borrowing costs or reduce facility availability, forcing asset sales or equity raises. The negative operating cash flow and 0.93 current ratio indicate limited liquidity buffers if credit lines are curtailed.
growth - The 68.6% revenue growth, negative margins, and negative free cash flow profile attracts growth investors betting on portfolio scale-up and eventual profitability inflection as policies mature. The 38.7% three-month return suggests momentum traders are active. Alternative asset specialists seeking non-correlated longevity exposure also participate, though the $0.8B market cap limits institutional ownership. Not suitable for value or income investors given negative earnings and no dividend.
high - Small-cap alternative asset manager with binary outcomes driven by mortality timing creates elevated volatility. Quarterly earnings swings from actuarial revaluations and lumpy death benefit collections amplify price movements. The -351.8% net income growth and -300% EPS growth demonstrate earnings instability. Limited float and analyst coverage exacerbate volatility during periods of sector rotation or credit market stress.
